However, effects on advanced fibrosis remain under investigation, with phase 2 trials of semaglutide showing MASH resolution without confirmed fibrosis improvement
Factors specific to retatrutide that might affect real-world outcomes include: The higher side effect rate could drive more discontinuations The heart rate increase might concern prescribers and lead to lower maintenance doses If pricing is higher than tirzepatide, cost barriers could limit access and adherence The more complex triple-agonist mechanism may require more careful monitoring, adding burden Conversely, the additional metabolic benefits (liver fat reduction, possibly better muscle preservation) might improve adherence by providing visible results beyond scale weight, motivating continued use
3 Recoger en una farmacia local Te enviaremos tu Wegovy Enva la receta a la farmacia que elijas para que la recojas
These modifications distinguish it from natural peptides and contribute to its stability
Zebound, meanwhile, was the company's fourth-best-selling drug at $1.22 billion in sales in Q2